Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
February 4th, 2021
In this study, we describe the process of T lymphocyte isolation from fresh samples of calcified aortic valves and the analytical steps of T cell-cloning for the characterization of the adaptive leukocyte subsets by using flow cytometry analysis.
This protocol is easy to perform. The cloning phase allows a larger number of T clones to be obtained from fresh samples. Moreover, the phenotype and function of T cells can easily be analyzed.
Demonstrating the procedure will be Mary Christopher, a doctorate student from my laboratory. To induce T-cell cloning, use the bag spike with the needle-free valve to open an irradiated buffy coat bag in a laminar flow hood. Transfer up to 50 milliliters of blood from the bag into a T-150 flask, and add 70 milliliters of PBS to the flask.
Carefully layer 30 milliliters of the diluted blood onto 20 milliliters of density gradient in each of four 50 milliliter conical tubes, and separate the cells by density gradient centrifugation. Carefully aspirate the supernatant, and transfer the PBMC from each tube into a single new 50 milliliter tube. Use PBS to bring the final volume to 50 milliliters and collect the PBMC by centrifugation.
After a second wash under the same conditions, suspend the isolated feeder cells in 10 milliliters of cell culture medium for counting, and add 25 milliliters of a 70 milliliter cell culture medium supplemented with 50 units of IL-2 solution into each of two 50 milliliter tubes. Then add feeder cells to one tube at a 2 by 10 to the 6th cells per milliliter of cell culture medium supplemented with IL-2 concentration. To set up a T lymphocyte culture, pool the T cell clone containing supernatants from stenotic valve sample flask into a single 50 milliliter tube, and collect the cells by centrifugation.
Wash the pellet three times in 50 milliliters of PBS per wash, before resuspending the cells in 1 milliliter of cell culture medium for counting. Dilute the cells to a 1 by 10 to the 3rd cells per milliliter concentration, and add 500 microliters of cells to the tube of cell culture medium supplemented with IL-2 without feeder cells. Add the feeder cell suspension to a plastic 100 by 15 milliliter Petri dish, and add 100 microliters of feeder cells to each well of the appropriate number of U-bottom 96-well plates for the experiment.
Then add the T-cells to a Petri dish, and add 100 microliters of T-cells to each feeder cell supplemented well for a one week incubation in the cell culture incubator. The PBMC isolation is vital for obtaining feeder cells and enabling the detection and characterization of infiltrating leukocytes in aortic valve samples. After two weeks of incubation, a clone T-cell population can be obtained.
Here, the gating scheme for analyzing T-cell subpopulations in patients with calcific aortic valve disease is shown. As observed in this patient, there were more CD4+T-cells than CD8+T-cells. Flow cytometric analysis of uncloned T-cells confirms that the same T-cell markers are present in both native valve and clone samples.
Taken together, these data indicate that T-cells are present in calcified aortic valves with CD45+leukocytes, suggesting that calcific aortic valve disease is linked with activation of the immune system and inflammatory activity. This method is very versatile. It can be applied to different protocols for which researcher need to be able to isolate cells from a tissue, for the functional characterization.
Keep in mind that it is important to work under sterile conditions to avoid contamination, and to critically observe the cells under the microscope.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a protocol for isolating, cloning, and analyzing T lymphocytes from calcified aortic valve tissue to investigate their role in calcific aortic valve disease (CAVD). The method combines tissue dissection, cell culture, and flow cytometry to characterize T cell populations and their involvement in the pathophysiology of CAVD.
Key Study Components
Area of Science
- Immunology
- Cardiovascular research
- Cell biology
Background
- CAVD is a progressive disease leading from mild valve thickening to severe calcification and high mortality.
- The mechanisms linking valve calcification to severe aortic stenosis are not fully understood.
- T lymphocytes are present in stenotic valve tissue and may play a role in disease progression.
- Studying T cells from valve tissue can clarify their contribution to CAVD pathogenesis.
Purpose of Study
- To isolate and clone T lymphocytes from calcified aortic valve samples.
- To analyze T cell subpopulations and their phenotypes using flow cytometry.
- To better understand the involvement of adaptive immunity in CAVD.
Methods Used
- Surgical excision and dissection of fresh aortic valve tissue.
- Isolation of peripheral blood mononuclear cells (PBMCs) via density gradient centrifugation.
- Cloning and culturing of T lymphocytes with feeder cells and IL-2 supplementation.
- Staining and analysis of T cell clones using fluorescence activated cell sorting (FACS)/flow cytometry.
Main Results
- The protocol enables efficient isolation and expansion of T cell clones from valve tissue.
- Flow cytometry reveals the presence of both CD4+ and CD8+ T cell subpopulations, with a predominance of CD4+ T cells in some patients.
- Similar T cell markers are observed in both native valve and cloned T cell samples.
- T cells are present alongside CD45+ leukocytes in calcified valves, indicating immune activation and inflammation in CAVD.
Conclusions
- This method provides a reliable approach for isolating and characterizing T cells from calcified aortic valves.
- The protocol is versatile and can be adapted for functional studies of tissue-infiltrating immune cells.
- Findings support a link between immune activation and the pathophysiology of CAVD.
Frequently Asked Questions
Executive Industry Relevance
Clarifying the immunological mechanisms underlying calcific aortic valve disease (CAVD) is critical for de-risking early cardiovascular target hypotheses and informing translational biomarker strategies. The isolation and phenotypic analysis of T lymphocytes from calcified valve tissue enables direct interrogation of adaptive immune involvement, supporting predictive confidence in disease-relevant pathways. This workflow positions immune cell profiling as a pivotal inflection point for portfolio decisions in cardiovascular R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct assessment of T cell infiltration and activation in diseased valve tissue.
- Supports mechanistic de-risking by linking immune cell phenotypes to CAVD pathology.
- Facilitates functional target validation for immune-modulatory interventions.
- Provides data to triage cardiovascular targets based on adaptive immunity involvement.
Screening & Assay Development
- Establishes a validated workflow for isolating and expanding primary T cell clones from human tissue.
- Delivers reproducible, quantitative flow cytometry outputs for immune cell subpopulation analysis.
- Enables standardized staining and fixation protocols for batch analysis and cross-study comparability.
- Prepares disease-relevant immune cell systems for downstream functional assays.
Translational & Preclinical Research
- Aligns immune cell profiling with disease-relevant human tissue, enhancing translational continuity.
- Supports identification of immune biomarkers for patient stratification in preclinical models.
- Provides mechanistic insights to inform risk-adjusted advancement of cardiovascular assets.
- Enables functional characterization of tissue-infiltrating lymphocytes for preclinical validation.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling immune cell isolation, phenotyping, and functional analysis directly from human valve tissue.
- Discovery Biology: Supports hypothesis testing on immune involvement in CAVD and clarifies adaptive immune pathways.
- Screening: Delivers standardized, quantitative flow cytometry data for immune cell subpopulations.
- Analytics: Provides robust measurements of T cell phenotypes and activation states for comparative studies.
- Translational Research: Bridges human tissue findings to preclinical immune biomarker development.
- Enterprise Reuse: Offers a versatile protocol adaptable to other tissue-infiltrating immune cell studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune-mediated mechanisms of CAVD.
- Operational Value: Standardizes immune cell isolation and analysis for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions for immune-targeted cardiovascular programs.
- Portfolio Impact: Enables risk-adjusted prioritization of assets based on mechanistic immune data.
Implementation Considerations
- Requires expertise in sterile tissue handling and primary immune cell culture.
- Needs access to flow cytometry instrumentation and analytical infrastructure.
- Demands cross-team standardization of staining and gating protocols for data comparability.
- Adaptable to various tissue sources for broader immune cell characterization.
- Dependent on fresh tissue availability and rigorous contamination control.
